EPO Patents = 1

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

Wentao Huang (5 out of 13 patents)

Runsheng Li (5 out of 13 patents)

Ying Qin Zang (4 out of 4 patents)

4. Zhifang Liu (3 out of 3 patents)

5. Yifan Li (1 out of 15 patents)

6. Fang Sun (1 out of 3 patents)

7. Youni Zhan (1 out of 1 patent)

8. Wei Cao (1 out of 3 patents)

6 patents: Sort by Forward Citations

1. 12291537 - Compounds, compositions and methods (2025-05-06),

2. 12247081 - CEACAM5-dependent 4-1BB-agonistic bispecific antibodies (2025-03-11),

3. 12194106 - Antibodies targeting LIV-1 and uses thereof (2025-01-14),

4. 12180276 - Antibodies and antibody-drug conjugates targeting claudin 6 (2024-12-31),

5. 11873342 - Anti-CCR8 monoclonal antibodies and uses thereof (2024-01-16),

6. 10882853 - Tyrosine kinase inhibitor and application thereof (2021-01-05),

Lanova Medicines Limited is a pharmaceutical company dedicated to the development and commercialization of innovative therapies for various health conditions. The company specializes in research that targets unmet medical needs, focusing on areas such as chronic diseases and rare disorders. Lanova is committed to advancing drug development through state-of-the-art scientific research and collaboration with healthcare professionals. Their pipeline includes several promising candidates that are undergoing clinical trials. With a strong emphasis on quality and regulatory compliance, Lanova aims to deliver safe and effective medications to improve patient outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#340 in Shanghai

#3,927 in China

Shanghai, China

Lanova Medicines Limited